dr. kapil bhalla on sensitizing tnbc to cisplatin with hdac inhibitors
Published 11 years ago • 216 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
1:37
dr. kapil bhalla on using hdac inhibitors to sensitize tnbc to parp inhibitors and cisplatin
-
1:31
dr. bhalla on dna-damaging agents in breast cancer
-
1:45
dr. sikov on bevacizumab or carboplatin impact on tnbc subtype
-
0:47
what are the surgical treatment options? - questions about breast cancer
-
0:48
targeting c/ebpβ in melanoma
-
1:51
optimal chemotherapy combinations in tnbc gbrca subtypes
-
5:07
chenguang peng - pfb psne-facilitated ablation (2020)
-
1:17
if you have breast cancer watch this
-
23:39
educational sessions: "io vs capecitabine for tnbc"
-
0:54
why is io unsucessful in non-tnbc?
-
1:31
dr. tripathy on ixabepilone in patients with tnbc
-
1:06
what radiation options follow lumpectomy? - questions about breast cancer
-
2:00
dr. hurvitz on treatment hypotheses for tnbc
-
4:18
diagnostic concordance in interpreting breast biopsies
-
1:47
better biopsy to detect breast cancer
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer
-
1:33
dr. chaft on the rise of immunotherapy in lung cancer
-
5:09
tcsics using vectis
-
3:02
from biopsy to diagnosis